Search

Your search keyword '"Antineoplastic agents -- Health aspects -- Product information"' showing total 5 results
Start Over Descriptor "Antineoplastic agents -- Health aspects -- Product information"
5 results on '"Antineoplastic agents -- Health aspects -- Product information"'

1. Darinaparsin (Zinapar or ZIO-101, Ziopharm Oncology)

Subjects
Antineoplastic agents -- Health aspects -- Product information, Biotechnology industry -- Product information, T cell lymphoma -- Drug therapy, Antimitotic agents -- Health aspects -- Product information, Pharmaceuticals and cosmetics industries, Zinapar (Medication) -- Product information
Abstract

Darinaparsin (Zinapar or ZIO-101, Ziopharm Oncology) for the treatment of peripheral T-cell [...]

Published
2010

2. Oncophage

Subjects
Antigenics Inc. -- Product information, Oncophage (Vaccine) -- Health aspects -- Product information, Antineoplastic agents -- Health aspects -- Product information, Biotechnology industry -- Product information -- Health aspects, Gliomas -- Drug therapy -- Product information -- Health aspects, Antimitotic agents -- Health aspects -- Product information, Pharmaceuticals and cosmetics industries, Drug therapy, Product information, Health aspects
Abstract

* Vitespen (Oncophage, Antigenics) for the treatment of [...]

Published
2009

3. At least 39 deaths linked to cancer drugs

Subjects
Yakult Honsha Company Ltd. -- Product information, Daiichi Pharmaceutical Corp. -- Product information, Campto (Medication) -- Health aspects -- Product information, Cancer patients -- Patient outcomes -- Product information -- Health aspects, Mortality -- Product information, Antineoplastic agents -- Health aspects -- Product information, Antimitotic agents -- Health aspects -- Product information, Health, Product information, Patient outcomes, Health aspects
Abstract

The Japanese Health and Welfare Ministry has linked at least 39 deaths to two kinds of anti-cancer drugs. Doctors have strongly warned of what they called abnormal mortality rates from [...]

Published
1997

4. Anticancer agent cleared for use in nine additional countries

Subjects
Rhone-Poulenc Rorer Inc. -- Product information, Taxotere (Medication) -- Health aspects -- Product information, Antineoplastic agents -- Health aspects -- Product information, Chemotherapy -- Product information -- Health aspects, Lung cancer, Non-small cell -- Product information -- Health aspects, Cancer -- Chemotherapy, Breast cancer -- Product information -- Health aspects, Antimitotic agents -- Health aspects -- Product information, Health, Product information, Health aspects
Abstract

Rhone-Poulenc Rorer Inc. (RPR), Collegeville, Pennsylvania, announced that Taxotere (docetaxel) has been cleared for use in Argentina, Russia, Israel, Pakistan, the Philippines, Romania, Slovakia and Ukraine for the treatment of [...]

Published
1996

5. A new weapon in the breast cancer arsenal

Subjects
ICI Pharmaceuticals -- Product information, Tamoxifen -- Health aspects -- Product information, Antineoplastic agents -- Health aspects -- Product information, Chemotherapy -- Product information -- Health aspects, Cancer -- Chemotherapy, Breast cancer -- Product information -- Health aspects, Antimitotic agents -- Health aspects -- Product information, Food/cooking/nutrition, Health, Product information, Health aspects
Abstract

Recent FDA approval of tamoxifen citrate (Nolvadex) as an adjunct form of therapy in some breast cancer patients provides a welcome addition to the various forms of therapy currently available [...]

Published
1991

Catalog

Books, media, physical & digital resources
See catalog results